Study on Mastocytosis for Rupatadine Treatment
NCT01481909
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Mastocytosis
Interventions
DRUG:
Rupatadin
Sponsor
Marcus Maurer